Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy

C ardiovascular disease (CVD) remains a highly prevalent cause of morbidity and mortality, both in the United States and worldwide.In parallel with the development of new and improved therapies for established CVD such as coronary artery disease or heart failure (HF), there has been an increased focus on modification of cardiovascular risk factors for both primary and secondary prevention, reflecting an evolving understanding of CVD as a systemic process with numerous determinants.Obstructive sleep apnea (OSA) has been associated with many different forms of CVD including hypertension, stroke, HF, coronary artery disease, and atrial fibrillation (AF). 1 Adults with OSA not only have an increased risk of developing comorbid CVD but also have worse outcomes related to CVD.OSA is highly prevalent, estimated to affect 34% of men and 17% of women in the general population 2 and 40% to 60% of patients with CVD. 3,4Furthermore, the prevalence is increasing, with these figures representing a 30% increase over the previous 2 decades, 2 likely related to the obesity epidemic as well as an aging population.Despite the clear association between CVD and OSA, randomized trials have failed to demonstrate that treatment of sleep apnea improves hard cardiovascular outcomes in patients with established CVD. 5 Nevertheless, this area remains controversial, as randomized trials performed to date remain limited in number as well as design, highlighting the need for further study. 6Furthermore, the current literature suggests that the impact of diagnosing and treating OSA varies between specific CVD processes, implying the need for a more sophisticated understanding and nuanced clinical approach to this issue.In this article we review the literature pertaining to OSA in patients with CVD.Additionally, we offer a practical clinical approach to the evaluation and management of known or suspected OSA in patients with CVD consisting of recommendations integrated from several separate societal practice guidelines combined with several of our own suggestions on issues not addressed by current guidelines, based on our own clinical experience and best available literature.